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Abstract
Background: Insulin resistance is characterized by deficient responses to insulin in its target tissues. In the present
study, we examined the effects of L-Citrulline (L-Cit) on insulin sensitivity and signaling cascades in rat hepatoma
H4IIE cells and SHRSP.Z-Leprfa/IzmDmcr rats.
Methods: H4IIE cells were pretreated in the presence or absence of 250 μM L-Cit in serum-free medium and then
incubated in the presence or absence of 0.1 nM insulin. Rats were allocated into 2 groups; a control group (not
treated) and L-Cit group (2 g/kg/day, L-Cit) and treated for 8 weeks.
Results: L-Cit enhanced the insulin-induced phosphorylation of Akt in H4IIE cells. Moreover, the inhibited expression of
Dex/cAMP-induced PEPCK mRNA by insulin was enhanced by the L-Cit treatment. The phosphorylation of tyrosine,
which is upstream of Akt, in insulin receptor substrate-1 (IRS-1) was increased by the L-Cit treatment. The L-Cit-
induced enhancement in insulin signaling was not related to the binding affinity of insulin to the insulin receptor
or to the expression of the insulin receptor, but to a decrease in the phosphorylation of serine 1101 in IRS-1.
These results were also confirmed in animal experiments. In the livers of L-Cit-treated rats, PI3K/Akt signaling was
improved by decreases in the phosphorylation of serine 1101.
Conclusions: We herein demonstrated for the first time the beneficial effects of L-Cit on improved insulin resistance
associated with enhanced insulin sensitivity. These results may have clinical applications for insulin resistance and the
treatment of type-2 diabetes.
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Background
Metabolic syndrome is a lifestyle-related disease caused
by a high nutrient condition or lack of exercise. The de-
velopment of insulin resistance due to obesity has
attracted attention as an underlying mechanism for the
basic background of metabolic syndrome. Insulin resist-
ance refers to reduced peripheral insulin sensitivity. The
binding of insulin to insulin receptors promotes the
phosphorylation of insulin receptor substrates (IRS)
and activates the intracellular intermediate phos-
phatidylinositol 3-kinase (PI3K), which, in turn, leads
to the phosphorylation of protein kinase B (Akt), a
serine/threonine-specific protein kinase [1, 2]. The acti-
vation of Akt in the liver inhibits gluconeogenesis by
predominantly suppressing the expression of genes for
the key gluconeogenic enzymes, phosphoenolpyruvate
carboxykinase (PEPCK) and glucose-6-phosphatase
(G6Pase). Therefore, insulin resistance in the liver is
characterized by deficient responses to insulin, such as
enhanced gluconeogenesis [3], which ultimately cause
or worsen hyperglycemia. Drug therapy for insulin re-
sistance is a recently developed approach that may im-
prove insulin resistance, but is associated with the risk
of side effects, which explains the utility of insulin re-
sistance control by the selection of appropriate foods
for safety.
L-citrulline (L-Cit) is one of the amino acids that are
found in large amounts in cucurbits including the
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watermelon [4]. Recent studies reported that some amino
acid supplementations influence insulin resistance [5, 6].
On the other hand, L-Cit has been shown to play a role in
the nitric oxide (NO) system in humans and potentially
has antioxidant and vasodilatory effects [7]: however, the
effects of L-Cit on insulin resistance have not yet been
examined.
We hypothesized that L-Cit may play a role in improv-
ing insulin sensitivity via the liver. Therefore, we herein
investigated the effects of L-Cit on insulin signaling im-
provements in rat hepatoma H4IIE cells, which have the
ability to produce glucose and have been used to develop
an obesity-related insulin-resistant model [8]. We also
examined the effects of L-Cit in vivo using SHRSP.Z-
Leprfa/IzmDmcr rats (SHRSP/ZF), which are resistant to
insulin.
Materials and methods
Cell culture and treatment
H4IIE cell (DS Pharma Biomedical Co., Ltd.) was used
between passage numbers 12 and 45. Cells were cul-
tured in 6-well tissue culture plates (Becton, Dickinson
and Company, Japan) and grown to near confluence in
Dulbecco's modified Eagle's medium (Nacalai Tesque,
Kyoto) containing 10 % fetal bovine serum at 37 °C
under a 5 % CO2 atmosphere. Cells were pretreated in
the presence or absence of 250 μM or 100 μM L-Cit
(supplied by Protein Chemical Co., Ltd., Japan) in
serum-free medium for 1 h and were then incubated
for 10 min in the presence or absence of 0.1 nM insu-
lin. In order to measure phosphoenolpyruvate carboxy-
kinase (PEPCK) gene expression, cells were treated for
6 h with 500nM Dexamethasone and 0.1 mM cAMP
(Dex/cAMP) to induce PEPCK gene expression to-
gether with 250 μM L-Cit and/or 10 nM insulin during
the same time frame.
Binding kinetics assays
We measured the binding kinetics of insulin and INSR
using Bio-Layer Inter-Ferometry (BLI) on Octet RED
(ForteBio, USA). All interaction analyses were conducted
at 30 °C in PBS buffer unless stated otherwise. Sensor
tips were pre-wet for 5 min in buffer immediately prior
to use, and the microplates used in the Octet were filled
with 200 μL of sample or buffer per well and agitated at
1000 g. The experiments comprised 5 steps: 1. Baseline
acquisition (120 s); 2. INSR. Loading onto the SA (Strep-
tavidin) sensor (1200 s); 3. Second baseline acquisition
(300 s); 4. Association of insulin for the measurement of
kon (300 s); and 5. Dissociation of insulin for the meas-
urement of koff (300 s). The concentration of insulin was
2 μM. Baseline and dissociation steps were carried out
in buffer with or without 250 μM L-Cit. Association and
dissociation responses (nm) were compared with or
without 250 μM L-Cit.
Animals
Five-week-old male SPF (Specific pathogen-free) SHRSP.Z-
Leprfa/IzmDmcr (SHRSP-fatty) rats were supplied by
Japan SLC (Shizuoka, Japan). All rats were housed in a
climate-controlled (temperature; 22 ~ 24 °C, humidity; 40
~ 60 %) light-regulated room with 12-h light and dark cy-
cles. These rats were fed normal chow (CE-2) for 1 week
to stabilize their metabolic condition. SHRSP-fatty rats
were allocated into 2 groups; a control group (n = 7, not
treated) and L-Cit group (n = 7, administrated 2 g/kg/
day L-Cit by free access to water). We referred to a previ-
ous study using Amino acid supplemental doses rate from
human to animals [28]. We measured water and food in-
takes as well as the body weights of rats daily.
All rats were sacrificed at the conclusion of the 8-week
treatment period after 12 h of fasting. Rats were anes-
thetized with pentobarbital (65 mg/kg body weight).
Blood samples were collected and sera were centrifuged,
frozen, and stored at −20 °C until later analyses. Two
rats of each group were selected at random and used for
formalin perfusion. The tissues were immediately har-
vested and cleaned to measure tissue weights, and the
liver was promptly frozen in liquid nitrogen and stored
at −80 °C for western blotting and gene analyses.
All procedures were carried out in accordance with
the guiding principles for the care and use of animals in
the field of physiological sciences established by the
Physiological Society of Japan, and the study was ap-
proved by the Ethics Committee of Laboratory Animals
at Mukogawa Women’s University.
Blood analysis
Serum glucose, cholesterol, triglyceride, and free fatty
acid levels were measured enzymatically using an
assay kit (Wako, Japan). The concentrations of serum
aspartate aminotransferase (AST) and alanine amino-
transferase (ALT) were measured using the corre-
sponding commercial enzyme kit (Wako, Japan).
Serum insulin levels were analyzed using the rat
ELISA kit (SHIBAYAGI Co., Ltd. Japan) following the
manufacturer’s protocol.
Extraction of membrane protein complexes
Isolated tissues were homogenized in 200 μl TBS
(0.025 M Tris–HCl, 0.15 M NaCl, pH7.2) and centri-
fuged at 1,000 × g for 5 min at 4 °C. Membrane proteins
were extracted with the Mem-PER Eukaryotic Mem-
brane Protein Extraction Kit (Thermo, Japan). The vis-
cous phase containing the membrane protein fraction
was collected and proteins were purified by precipitation
with 10 % trichloroacetic acid. Recovered proteins were
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Fig. 1 Effects of L-Cit on insulin signaling in H4IIE cells. H4IIE cells were treated with L-Cit for 1 h and stimulated for 10mins with 0.1nM insulin. a
Phosphorylation level of Akt at serine 473, (b) PEPCK mRNA level, (c) phosphorylation level of IRS1 at tyrosine, (d) protein level of IR. Data were
expressed as the mean ± SEM of three independent experiments. Significant differences were identified by Tukey’s test, #p < 0.05 vs control, *p < 0.05
vs with insulin
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mixed with SDS buffer, boiled for 5 min, and loaded
onto 12.5 % SDS-PAGE gels.
Primary and secondary antibodies
Immunoblotting was performed with the following
commercially available antibodies: anti-rabbit Akt, anti-
rabbit phospho-Akt (Ser473), anti-rabbit IRS-1, anti-
rabbit phospho-IRS-1 (Ser307, Ser612, Ser1101), anti-
rabbit IgG, and anti-mouse IgG from Cell Signaling
Technology (Beverly, MA). Anti-mouse INSRβ, anti-
rabbit phospho-IRS-1 (Tyr 989), and anti-goat PI3-
kinase p85α were from Santa Cruz Biotechnology.
Anti-mouse β-actin was obtained from Sigma (St.
Louis, Mo, US).
Western blot analysis
Cells were homogenized in ice-cold homogenized buffer
containing 50 mM Tris–HCl (pH7.4), 100 mM NaCl,
1 % Nonidet-P40, 0.25 % Na deoxycholate, 0.1 % SDS,
1 mM EDTA, 50 mM NaF, 2 mM Na3VO4, 30 mM Na
pyrophosphate, 2 mM PMSF, 1 mM benzamidine,
0.02 g/mL trypsin inhibitor, 0.02 g/mL leupeptin, and
0.02 g/mL aprotinin. After being incubated for 30 min,
lysates were centrifuged at 13,000 g for 10 min and su-
pernatants were isolated. The liver tissue was homoge-
nized in ice-cold homogenized buffer. After being
incubated for 2 h, lysates were centrifuged at 20,000 g
for 20 min and the supernatants were isolated. Proteins
were extracted by boiling the tissues in 0.5 mmol/l Tris/
HCl, pH6.8, glycerol, 10 % SDS, 0.1 % bromophenol
blue, and 2-mercaptethanol. The proteins (25 μg/lean)
were electrophoresed using 7.5 %-12.5 % SDS-PAGE gel
at 100 V for 2 h. After fractionating, the proteins were
transferred onto a PVDF membrane (Amersham Life
Science Inc. Buckinghamshire) at 100 mA for 2 h. The
membrane was blocked with Blocking One (Nacalai Tes-
que, Kyoto) for 20 min. After appropriate blocking, the
blot was incubated overnight with the primary antibody
in antibody solution 1 (Toyobo, Osaka). It was then
washed with TTBS and finally incubated for 1 h with a
1:10000 dilution of anti-rabbit, goat, and mouse IgG-
horseradish peroxidase. Detection was achieved using an
ECL kit (Nacalai Tesque, Kyoto). β-actin was used as an
internal control. The densities of the bands were mea-
sured using NIH Images.
Real-time PCR
Total RNA was extracted from H4IIE cells and livers
using Sepasol-RNA I Super G (Nacalai Tesque, Kyoto).
Total RNA from each sample was reverse transcribed to
cDNA using the ReverTra Ace qPCR RT kit (Toyobo).
The Thunderbird SYBR qPCR Mix was used for the
quantitative real-time RT-PCR analysis of the expression
of each gene. The primer sequences were as follows:
PEPCK sense, 5’-GCA GAG CAT AAG GGC AAG GT-
3’, and antisense, 5’-TTG CCG AAG TTG TAG CCA
AA-3’; β-actin sense, 5’-GGG AAA TCG TGC GTG
ACA TT -3’, and antisense, 5’-GCG GCA GTG GCC
ATC TC-3’. Amplification was performed with a real-
time PCR system (ABI Prism 7000). Results are
expressed as a relative value after normalization to the
expression of β-actin.
Statistical analysis
Data are expressed as the mean ± SEM. Statistical ana-
lyses of the data was performed by the Student’s t-test
between two groups. For multiple comparisons, one-way
analysis of variance followed by Tukey's test was deter-
mine the significance of differences. A p value of less
than 0.05 was considered significant.
Results
Effects of L-Cit on insulin signaling in H4IIE cells
We confirmed that 250 μM L-Cit was not cytotoxic
using the MTT method (data not shown). Akt is a cen-
tral enzyme in insulin signaling; therefore, we examined
the effects of L-Cit on the phosphorylation of Akt at
ser473. The treatment of H4IIE cells with L-Cit did not
affect the phosphorylation of Akt in the absence of insu-
lin, but did in the presence of insulin. A pretreatment
with L-Cit significantly elevated the phosphorylation of
Akt induced by the subsequent 10-min stimulation with
insulin (Fig. 1a). PEPCK is an important gluconeogenic
enzyme, and its expression is controlled by the insulin-
induced phosphorylation of Akt. Moreover, PEPCK gene
expression was previously shown to be increased by
Dex/cAMP and markedly repressed by insulin in H4IIE
cells [9]. H4IIE cells were stimulated with Dex/cAMP in
Fig. 2 Effects of L-Cit on insulin and its receptor binding. Affinities
(KD) were calculated from a non-liner global fit of the data between
the insulin receptor and insulin in the presence or absence of L-Cit
using the Octet software
Yoshitomi et al. BMC Complementary and Alternative Medicine  (2015) 15:188 Page 4 of 9
the presence or absence of L-Cit for 6 h. PEPCK gene
expression was significantly lower in the L-Cit and insu-
lin treatment groups than in the only insulin group
(Fig. 1b). Moreover, the L-Cit treatment enhanced the
phosphorylation of Tyr in IRS-1, which is an upstream
factor of Akt, in the presence of insulin (Fig. 1c). These
results indicated that L-Cit increased insulin sensitivity.
We then examined the protein expression of the insulin
receptor to determine whether insulin sensitivity in-
creased the effects of L-Cit and if this was related to the
expression of the insulin receptor. However, L-Cit did
not affect the expression of the insulin receptor in H4IIE
cells (Fig. 1d).
Effects of L-Cit on insulin and its receptor binding
Affinities (KD) were calculated from a non-liner global
fit of the data between the insulin receptor and insulin
in the presence or absence of L-Cit using the Octet soft-
ware. The KD (M) of the insulin receptor and insulin
was 5.72E-07. The KD (M) of the insulin receptor and
insulin with L-Cit was 4.78E-07. L-Cit had no significant
effect on the insulin binding affinities of the insulin re-
ceptor (Fig. 2).
Effects of L-Cit on the phosphorylation of serine in IRS-1
in H4IIE cells
IRS-1 plays an important role in insulin signaling. The
phosphorylation of Ser in IRS-1 reduces its ability to as-
sociate with the insulin receptor, leading to a reduction
in insulin signaling. In the present study, no significant
difference was observed in IRS-1 ser307 (Fig. 3a) or 612
(Fig. 3b) in the presence or absence of L-Cit. However,
the phosphorylation of IRS1 ser1101 was weaker in L-
Cit-treated H4IIE cells than in non-treated cells in the
presence of insulin (Fig. 3c), whereas no significant dif-
ference was observed in the absence of insulin.
Effects of L-Cit supplementation on insulin signaling in
SHRSP/ZF rat livers
The results obtained in SHRSP/ZF rats were consistent
with those in H4IIE cells. No significant differences were
observed in the phosphorylation of IRS-1 Ser307 and
612 in the liver between the groups (Fig. 4a, b). How-
ever, the phosphorylation of Ser1101 in IRS-1 was mark-
edly decreased in the L-Cit group (Fig. 4c). PI3K is a
downstream factor of IRS-1 and controls the
Fig. 3 Effects of L-Cit on the phosphorylation of serine in IRS-1 in
H4IIE cells. H4IIE cells were treated with L-Cit for 1 h and stimulated
for 10mins with 0.1nM insulin. a Phosphorylation level of IRS1 at
serine 307, (b) IRS1 at serine 612, (c) IRS1 at serine 1101. Data were
expressed as the mean ± SEM of three independent experiments.
Significant differences were identified by Tukey’s test, #p < 0.05 vs
control, *p < 0.05 vs with insulin
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phosphorylation of Akt. PI3K exhibits its effects by trans-
locating to the cell membrane from the cytoplasm [10,
11]. The ratio of cell membrane PI3K was significantly
higher in the L-Cit group than in the control group
(Fig. 4d). Furthermore, the level of phosphorylation of Akt
in the liver was significantly higher in the L-Cit group
than in the control group (Fig. 4e). PEPCK gene expres-
sion was slightly decreased in the L-Cit group (Fig. 4f).
No significant difference was observed in the protein
expression of the insulin receptor between the two groups.
Fig. 4 Effects of L-Cit supplementation on insulin signaling in SHRSP/ZF rat livers. Six-week-old male SHRSP/ZF rats were administrated 2 g/kg/day
L-Cit for 8 weeks. At the end of the administration period, the livers were immediately harvested for western blotting. a Phosphorylation level of IRS1
at serine 307, (b) IRS1 at serine 612, (c) IRS1 at serine 1101, (d) membrane PI3K level, (e) phosphorylation level of Akt at serine 473, (f) PEPCK mRNA
level. Data were expressed as the mean ± SEM of n = 5. Significant differences were identified by the t-test, *p < 0.05, **p < 0.01 vs control group
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Animal characteristics
Table 1 shows that supplementation with L-Cit did not
affect food intake or body weight. However, fasting glu-
cose levels were approximately 23 % lower in the L-Cit
group than in the control group 8 weeks after the ad-
ministration of L-Cit, whereas serum insulin concentra-
tions were similar in the two groups. No significant
differences were observed in triglyceride, cholesterol, or
FFA levels between the groups. AST and ALT also did
not differ significantly among the groups during the ex-
perimental period.
Discussion
The main result of the present study was that L-Cit in-
creased insulin sensitivity in rat hepatoma H4IIE cells
and SHRSP/ZF rats. The underlying mechanism was
identified as the stimulation of insulin signaling due to
the inhibited phosphorylation of serine1101 in IRS1.
Insulin is secreted by the pancreas in response to eat-
ing or other stimuli and functions to control blood glu-
cose levels. The binding of insulin to insulin receptors
leads to the phosphorylation of tyrosine in IRS, which
activates PI3K and subsequently phosphorylates Akt
[12]. Akt is an important factor in insulin signaling and
the control of glucose metabolism. Phosphoenolpyruvate
carboxykinase (PEPCK) is a rate-limiting enzyme that
catalyzes hepatic gluconeogenesis. Insulin has been
shown to suppress the transcription of PEPCK by acti-
vating Akt [13]. In the present study, we demonstrated
that L-Cit enhanced the insulin-induced phosphorylation
of Akt and reduced PEPCK mRNA expression. We also
showed that L-Cit increased the phosphorylation of tyro-
sine in IRS1, which is upstream of Akt, and this was not
related to the binding affinity of insulin to its receptor
or the expression of the insulin receptor.
In contrast to the phosphorylation of tyrosine, IRS1 is
known to be phosphorylated at many serine sites. Recent
studies reported that serine phosphorylation played an
important role as a mechanism that negatively regulated
insulin signaling [14, 15]. The phosphorylation of serine
in IRS-1 may suppress insulin signaling by downregulat-
ing the expression of the IRS1 protein through ubiquiti-
nation [16], thereby inhibiting the interaction between
the insulin receptor and IRS1 phosphotyrosine binding
domain [17, 18]. Many stimulators of IRS-1 serine phos-
phorylation have been identified to date, for example,
TNFα and FFA. TNFα phosphorylates serine 307, 612,
and 636 in IRS-1 through the activation of several serine
kinases including inhibitory-kappa-B kinase [19], JNK
[20], and mTOR [21]. FFA activates IKK or JNK and
phosphorylates IRS-1 serine 307. On the other hand,
FFA stimulates phosphorylation of serine 1101 through
PKCθ. A previous study reported that an insulin stimu-
lation also phosphorylated not only IRS1 on tyrosine
sites, but also that on serine residues such as Ser307,
Ser612, and Ser1101 [22]. This is part of the negative-
feedback mechanism induced by insulin. Therefore, in-
sulin resistance may be induced by high insulin level. In
the present study, we showed that the insulin stimula-
tion increased the phosphorylation of Ser307 and 612.
We observed that the phosphorylation of Ser1101 was
increased by the stimulation of insulin, but, devoid of
statistical significance. This may be due to high expres-
sion of IRS-1 serine1101 phosphorylate form on H4IIE
cell in normal condition. However, the activation of gen-
eral IRS1 may be controlled more by negative feedback.
Our results showed that the phosphorylation of Ser1101
was weaker in L-Cit-treated H4IIE cells than in non-
treated cells and its effects were detected in the presence
of insulin. No significant differences were observed in
IRS-1 ser307 and 612 in the presence or absence of L-
Cit. These results indicated that L-Cit diminished the in-
activation of IRS1 from insulin negative-feedback by de-
creasing phosphor-IRS-1 ser1101.
Thus, we conducted an additional experiment using
rats to confirm the insulin resistance-improving effects
of L-Cit in vitro. SHRSP/ZF which was generated as a
new model of metabolic syndrome by crossing SHRSP
rats with Zucker Fatty rats. SHRSP/ZF rats become
obese, hyperlipidemic, and resistant to insulin due to a
mutated leptin receptor [23]. Hence, these rats were char-
acteristically associated with hyperinsulinemia. When in-
sulin levels remain elevated for a long period of time, the
phosphorylation of serine in IRS1 may trigger insulin re-
sistance in cells. The phosphorylation of serine residues in
IRS1 was previously reported to be increased in models of
insulin resistance and type-2 diabetes [24]. The results of
the present study were consistent with in vitro findings in
which PI3K/Akt/PEPCK signaling in the liver was
Table 1 Effects of L-Citrulline on metabolic parameters in
SHRSP/ZF rat
Control (n = 7) L-Citrulline (n = 7)
food intake (g) 0w 24.0 ± 0.5 24.7 ± 0.4
4w 29.9 ± 0.5 29.4 ± 0.3
8w 30.5 ± 2.2 29.5 ± 2.6
2.6body weight (g) 0w 121.9 ± 5.9 127.3 ± 4.2
4w 330.7 ± 4.4 339.4 ± 7.6
8w 420.5 ± 5.9 415.0 ± 12.2
serum
insulin (ng/mL) 8.1 ± 3.6 10.8 ± 2.7
glucose (mg/dL) 280.2 ± 35.3 213.9 ± 16.6
triglyceride (mg/dL) 598.7 ± 99.5 594.4 ± 66.1
cholesterol (mg/dL) 94.6 ± 3.5 101.7 ± 3.0
free fatty acid (mEq/L) 1.8 ± 0.4 2.1 ± 0.4
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improved by the L-Cit treatment. Furthermore, only the
phosphorylation of Ser1101 in IRS-1 was decreased.
Various studies have shown that there is considerable
crosstalk between insulin signaling and amino acids.
For example, early studies reported that the plasma
concentrations of branched-chain amino acids were el-
evated in obese insulin-resistant subjects [25]. In con-
trast, Tremblay indicated that amino acid-induced
insulin resistance was linked to the S6K1-mediated
phosphorylation of Ser1101 in IRS-1 [26]. Ser1101, the
unphosphorylated form of IRS-1, enhanced the insulin-
induced tyrosine phosphorylation of IRS-1 and Akt
Ser473 phosphorylation. We also found that L-Cit sup-
plementation decreased the phosphorylation of Ser1101
in IRS1; however, the molecular mechanisms respon-
sible for this decrease currently remain unclear.
In summary, we herein demonstrated for the first time
the beneficial effects of L-Cit on improved insulin resist-
ance associated with enhanced insulin sensitivity
through the activation of IRS1 followed by the inhibition
of serine 1101 phosphorylation both in vivo and in vitro
(Fig. 5). L-Cit is a naturally occurring amino acid and
widely may exist for different tissue. Few studies have
demonstrated on the toxicology of supplemental L-Cit,
it is generally recognized as safe for oral administration
[27]. These results may have clinical applications for
insulin resistance and the treatment of type-2 diabetes
without side effects.
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